SNDX Operating Cash Flow
Syndax Pharmaceuticals Inc · Operating Cash Flow
SNDX Operating Cash Flow
Latest reported-$220.64Mperiod ending
SNDX TTM Operating Cash Flow (-$7.30M → -$220.64M)
TTM operating cash flow
High-resolution chart · PNG
SNDX operating cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -220,640,000 | |
| -278,163,000 | |
| -322,980,000 | |
| -310,880,000 | |
| -302,667,000 | |
| -286,517,000 | |
| -274,903,000 | |
| -258,864,000 | |
| -241,195,000 | |
| -204,921,000 | |
| -160,601,000 | |
| -142,146,000 | |
| -126,037,000 | |
| -130,972,000 | |
| -133,675,000 | |
| -10,072,000 | |
| -6,472,000 | |
| 9,789,000 | |
| 29,131,000 | |
| -87,209,000 | |
| -80,562,000 | |
| -77,924,000 | |
| -71,260,000 | |
| -68,356,000 | |
| -58,588,000 | |
| -49,706,000 | |
| -50,612,000 | |
| -52,928,000 | |
| -62,868,000 | |
| -65,492,000 | |
| -68,531,000 | |
| -66,210,000 | |
| -57,922,000 | |
| -54,573,000 | |
| -47,371,000 | |
| -45,065,000 | |
| -46,332,000 | |
| -41,422,000 | |
| -35,157,000 | |
| -29,036,000 | |
| -22,770,000 | |
| -19,876,000 | |
| -2,428,000 | |
| -1,608,000 | |
| 972,000 | |
| 1,164,000 | |
| -14,393,000 | |
| -13,674,000 | |
| -13,199,000 | |
| -10,322,000 | |
| -7,295,000 | |
| -4,540,065 |